世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のポリオワクチン市場 2018-2022年

Global Polio Vaccines Market 2018-2022

IRTNTR23970

 

出版社 出版年月電子版価格 ページ数
TechNavio
テクナビオ
2018年10月US$2,500
シングルユーザライセンス
96

サマリー

この調査レポートは世界のポリオワクチン市場を分析・予測したTechNavioの市場調査報告書です。

Description

About Polio
Polio is a highly contagious disease caused by a human enterovirus of the Picornaviridae family, resulting in paralysis or death. Two types of polio vaccination are available, OPV and IPV. The incidence of polio has been decreasing owing to initiatives by governments globally to drive immunization against the infection.
Technavio’s analysts forecast the Global Polio Vaccines Market to grow at a CAGR of 17.65% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the polio vaccines market. To calculate the market size, the report considers the revenue generated from the retail sales of polio vaccines across the globe.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, polio vaccines market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Astellas Pharma
- GlaxoSmithKline
- Sanofi
- Serum Institute of India
Market driver
- Increased funding for the development of various types of polio vaccine
- For a full, detailed list, view our report


Market challenge
- Lack of effective cold chain logistic
- For a full, detailed list, view our report

Market trend
- Cessation of oral polio vaccine
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors-

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.



目次

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: PIPELINE ANALYSIS
- Pipeline analysis
PART 06: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 07: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 08: MARKET SEGMENTATION BY VACCINE TYPE
- Segmentation by vaccine type
- Comparison by vaccine type
- OPV - Market size and forecast 2017-2022
- IPV - Market size and forecast 2017-2022
- Market opportunity by vaccine type
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas - Market size and forecast 2017-2022
- EMEA - Market size and forecast 2017-2022
- APAC - Market size and forecast 2017-2022
- Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 13: MARKET TRENDS
- Cessation of oral polio vaccine
- Ensuring vaccination in conflict zones and countries with weak health systems
PART 14: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 15: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Astellas Pharma
- GlaxoSmithKline
- Sanofi
- Serum Institute of India
PART 16: APPENDIX
- List of abbreviations

?

?
Exhibit 01: Parent market
Exhibit 02: Global human vaccines market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Pipeline drugs under phase III development
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2017
Exhibit 08: Validation techniques employed for market sizing 2017
Exhibit 09: Global polio vaccines market - Market size and forecast 2017-2022 ($ mn)
Exhibit 10: Global polio vaccines market - Year over year growth 2018-2022 (%)
Exhibit 11: Five forces analysis 2017
Exhibit 12: Five forces analysis 2022
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition - Five forces 2017
Exhibit 19: Global polio vaccines market by vaccine type - Market share 2017-2022 (%)
Exhibit 20: Comparison by vaccine type
Exhibit 21: Global polio vaccines market by OPV - Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Global polio vaccines market by OPV - Year over year growth 2018-2022 (%)
Exhibit 23: Global polio vaccines market by IPV - Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Global polio vaccines market by IPV - Year over year growth 2018-2022 (%)
Exhibit 25: Market opportunity by vaccine type
Exhibit 26: Customer landscape
Exhibit 27: Global polio vaccines market by region - Market share 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: Polio vaccines market in Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 30: Polio vaccines market in Americas - Year over year growth 2018-2022 (%)
Exhibit 31: Top three countries in Americas
Exhibit 32: Polio vaccines market in EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Polio vaccines market in EMEA - Year over year growth 2018-2022 (%)
Exhibit 34: Top three countries in EMEA
Exhibit 35: Polio vaccines market in APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 36: Polio vaccines market in APAC - Year over year growth 2018-2022 (%)
Exhibit 37: Top three countries in APAC
Exhibit 38: Market opportunity
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Astellas Pharma overview
Exhibit 45: Astellas Pharma - Business segments
Exhibit 46: Astellas Pharma - Organizational developments
Exhibit 47: Astellas Pharma - Geographic focus
Exhibit 48: Astellas Pharma - Key offerings
Exhibit 49: GlaxoSmithKline overview
Exhibit 50: GlaxoSmithKline - Business segments
Exhibit 51: GlaxoSmithKline - Organizational developments
Exhibit 52: GlaxoSmithKline - Geographic focus
Exhibit 53: GlaxoSmithKline - Segment focus
Exhibit 54: GlaxoSmithKline - Key offerings
Exhibit 55: Sanofi overview
Exhibit 56: Sanofi - Business segments
Exhibit 57: Sanofi - Organizational developments
Exhibit 58: Sanofi - Geographic focus
Exhibit 59: Sanofi - Segment focus
Exhibit 60: Sanofi - Key offerings
Exhibit 61: Serum Institute of India overview
Exhibit 62: Serum Institute of India - Business segments
Exhibit 63: Serum Institute of India - Organizational developments
Exhibit 64: Serum Institute of India - Key offerings








 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る